Skip to main content
. 2004 Jan 31;62(3):75–110. doi: 10.1016/j.antiviral.2003.12.006

Table 2.

Efficacy of CAIV-T on culture-confirmed influenza infection

CAIV-T subject (%) Placebo subject (%) Efficacy (%) (95% CI)

Number of subjects 1656 1115
All culture-confirmed influenza 50 (3.0) 131 (11.7) 74.3 (64.1, 81.8)
A/H1N1 (including H1N2) 20 (1.2) 76 (6.8) 82.3 (7.07, 89.8)
A/H3N2 4 (0.2) 24 (2.2) 88.8 (67.3, 97.2)
B 26 (1.6) 35 (3.1) 50.0 (14.5, 71.1)